000 | 01856cam a2200349 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223030601.0 | ||
008 | 120307s2011 ua d f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aPh.D | ||
099 | _aCai01.11.28.Ph.D.2011.Ha.N | ||
100 | 0 | _aHani Abdelsalam Mahmoud Elmikaty | |
245 | 1 | 0 |
_aNeonatal fetuin-A and adiponectin levels in high risk pregnancies / _cHani Abdelsalam Mahmoud Elmikaty ; Supervised Iman Abdelsalam Seoud , Nagwa Abdallah Mahmoud , Heba Hani Abou Hussein |
246 | 1 | 5 | _aقياس مستوي الفتوين-أ و الاديبونيكتين في حديثي الولادة بعد الحمل ذو الخطورة العالية |
260 |
_aCairo : _bHani Abdelsalam Mahmoud Elmikaty , _c2011 |
||
300 |
_a284 P. : _bcharts ; _c25cm |
||
502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pediatrics | ||
520 | _aFetuin-A, is produced by the liver and placenta a natural inhibitor of the insulin receptor tyrosine kinase in liver and skeletal muscle. Adiponectin is an adipocyte-derived peptide with anti-inflammatory effects. This study was conduucted on 80 newborn babies, Fetuin-A levels were found to be significantly high in all high risk groups. No significant differences in adiponectin levels were found. No correlation was found between Fetuin-A and adiponectin in all groups of the study | ||
530 | _aIssued also as CD | ||
653 | 4 | _aAdiponectin | |
653 | 4 | _aFetuin-A | |
653 | 4 | _aHigh risk pregnancy | |
700 | 0 |
_aHeba Hani Abou Hussein , _eSupervisor |
|
700 | 0 |
_aIman Abdelsalam Seoud , _eSupervisor |
|
700 | 0 |
_aNagwa Abdallah Mahmoud , _eSupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aNazla _eRevisor |
||
905 |
_aSamia _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c37747 _d37747 |